期刊文献+

抗结核候选药PA-824的合成研究 被引量:3

Synthesis Research of PA-824 as Anti-tuberculosis Candidate
下载PDF
导出
摘要 探索了一种合成PA-824的新方法:以2,4-二硝基咪唑(2)和缩水甘油丁酸酯(8)为原料发生亲核开环反应得到化合物(S)-1-(叔丁基二甲基硅氧基)-3-(2,4-二硝基-1H-咪唑-1-)丙-2-醇(9),然后用四氢-2H-吡喃(DHP)保护羟基,再经水解,合环,脱保护基,烷基化得到PA-824(1),总收率35%。 A new method to synthesis PA - 824 was introduced in this article. The initial step is the ring - opening of (S) - glyeidyl butyrate ( 8_ ) by 2,4 - dinitroimidazole ( 2_ ) to give the (S) - 3 - ( 2,4 - dinitro - 1 n - imidazol -1 -yl) -2- hydroxypropyl butyrate(9), followed protection by DHP, and then hydrolysis, cyclization, deprotection to give goal compound PA -824 (1) in 35% overall yield.
出处 《化工时刊》 CAS 2010年第4期32-34,51,共4页 Chemical Industry Times
关键词 PA-824 抗结核 合成 PA - 824 anti - tuberculosis synthesis
  • 相关文献

参考文献6

  • 1Emma C Rivers,Ricardo L Mancera.New anti-tuberculosis drug with novel mechanisms of action[J].Current Medicinal Chemistry,2008,15(19):1956-1967.
  • 2Patho Genesis Corp.Nitroimidazole antibacterial compounds and methods of use thereof[J],World Patent,WO97/01562,1997.
  • 3Reddy Damavarapu.,et al.2,4-Dinitroimidazole-a less sensitive explosive and propellant made by thermal rear-rangemeut of molten 1,4-dinitromi dazole[D].American Patent.US5387297,1995.
  • 4肖继强.对甲苯磺酸吡啶盐的制备方法.CN1037333A,1989.
  • 5Akihiro Orita,Kai Miwa,Genta Uenta.,et al.Integration of solventless reaction in a muti-step process:application to an efficient synthesis of PA-824[J].Adv.Synth.Catal.2007,349(13):2136-2144.
  • 6Pilho Kim,Liang Zhang,Ujjini H Manjunatha.,et al.Structure-activity relationships of antitubercular nitroimidazoles.1.structural features associated with aerobic and anaerobic activities of 4-and 5-nitroimidazoles[J].J.Med.Chem.2009,52(5):1317-1328.

同被引文献16

  • 1高凌玉,周建琴,孙承航.抗结核候选新药PA-824的研究进展[J].国外医药(抗生素分册),2006,27(6):241-244. 被引量:8
  • 2Danby G, Gaillard J M, Goulianos K, et al. Observation of high-energyneutrino reactions and the existence of two kinds of neutrinos[J]. PhysicalReview Letters, 1962,9(1):36.
  • 3Nuermberger E, Rosenthal I,Tyagi S, et al. Combination chemotherapywith the nitroimidazopyran PA-824 and fi rstline drugs in a murine model oftuberculosis[J]. Antimicrob Agents Chemother,2006,50:2621–2625.
  • 4Stover C K, Warrener P, VanDevanter D R, et al. A small moleculenitroimidazopyran drug candidate for the treatment of tuberculosis[J]. Nature2000,405:962–966.
  • 5Lenaerts A J, Gruppo V, Marietta K S, et al. Preclinical testing of thenitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis ina series of in vitro and in vivo models[J]. Antimicrob. Agents Chemother,2005,49:2294–2301.
  • 6Pilho Kim, Liang Zhang, et al. Structure-Activity Relationships ofAntitubercular Nitroimidazoles. 1. Structural Features Associated with Aerobicand Anaerobic Activity of 4- and 5-Nitroimidazoles[J]. Journal of Medicinal ofChemistry. 2009,52:1317-1328.
  • 7Integration of Solventless Reaction in a Multi-Step Process: Application toan Efficient Synthesis of PA-824[J]. Adv.Synth.Catal.2007,349: 2136-2144.
  • 8许寅,孟现民,张永信.耐药结核病流行现状及抗结核药物研究进展[J].上海医药,2013,34(13):3-7. 被引量:9
  • 9高琴,黄鑫,江振洲,张陆勇.具有抗结核活性的硝基咪唑类化合物的研究进展[J].药学与临床研究,2013,21(5):551-556. 被引量:13
  • 10许红霞,杨少辉,邢健昆.新型抗结核药及其候选药物的研究进展[J].中国药房,2015,26(4):553-557. 被引量:4

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部